Go Back To Menu
Close
- Mailing Form
-
Medical Report*
-
Go Back To Menu
Stomach cancer mainly originates from gastric mucosal epithelial cells and is a malignant tumor of the digestive tract. It is more common among middle-aged and elderly people over the age of 50. However, in both low- and high-incidence countries, the incidence of gastric cancer (cardia and non-cardia) in young adults under 50 has been increasing. Stomach cancer progresses rapidly, with no obvious symptoms in the early stage, often leading to diagnosis at an advanced stage. Its pathogenesis is complex, involving environmental, dietary, and genetic factors. With a large number of cases worldwide, stomach cancer has become a major public health concern.
The incidence of stomach cancer is high in East Asian countries, especially China, Japan, and South Korea. Other regions, such as parts of South America and Eastern Europe, also report high incidence. In Western developed countries, the incidence is relatively lower but still rising due to aging populations. The global burden of stomach cancer treatment is enormous, requiring effective scientific solutions.
The incidence of stomach cancer varies by region, as follows:
● The highest incidence is found in East Asia (Mongolia, China, Korea, and Japan), the Andes region of South America, and Eastern Europe.
● The lowest incidence is seen in North America, Northern Europe, and most countries in Africa and Southeast Asia.
In the United States, more than 26,000 new cases of stomach cancer are diagnosed each year, with about 11,000 deaths.
● More than 70% of gastric cancer cases occur in resource-limited countries.
1. Strong invasiveness
Stomach cancer cells easily spread to nearby tissues and distant organs, leading to severe complications such as gastrointestinal bleeding, perforation, and ascites, threatening patients’ lives.
2. Impaired digestive function
Stomach cancer can narrow the gastric cavity, obstruct food passage, and cause nausea, vomiting, and malnutrition, severely affecting daily life.
3. Difficult to treat
Because early gastric cancer has no obvious symptoms, it is easily overlooked, causing patients to miss the best treatment opportunity. Advanced gastric cancer has poor treatment outcomes and reduced survival rates.
4. Heavy psychological burden
Patients often suffer from anxiety and depression due to the disease and side effects of treatment. Quality of life is affected, making psychological support equally important.
Immune reconstruction cell therapy works by reinfusing immune cells derived from the patient or other verified sources to help rebuild an anti-tumor immune environment, thereby enhancing the body’s ability to recognize and eliminate cancer cells. This therapy can be combined with traditional methods such as surgery and chemoradiotherapy, improving treatment tolerance and efficacy, especially for patients with advanced or recurrent gastric cancer.
During treatment, cancer patients often suffer from weakened immunity, higher infection risks, and delayed recovery due to surgery or chemoradiotherapy. To better support patients through treatment, improve tolerance, and enhance survival, different immune reconstruction strategies must be scientifically planned in stages.
● Short-term strategy: Rapidly boost immunity through immune cell reinfusion to enhance anti-cancer treatment efficacy.
● Mid-term strategy: Reduce the side effects of traditional therapies, promote recovery, and complete standardized treatments.
● Long-term strategy: Comprehensive immune system rebuilding, including immune cell, gut immunity, elemental immunity, and nutritional immune reconstruction, to improve immunity, enhance quality of life, and extend survival.
1. Surgical treatment
Surgical resection remains the preferred curative method for gastric cancer. With technological advances, laparoscopic and other minimally invasive surgeries are widely applied, reducing trauma, shortening recovery, and improving postoperative quality of life.
2. Chemotherapy
Chemotherapy is commonly used as adjuvant therapy to inhibit cancer cell spread. Common drugs include fluorouracil and cisplatin, often combined with targeted drugs to enhance effectiveness.
3. Radiotherapy
Radiotherapy is mainly used as adjuvant therapy after surgery or for late-stage control, reducing tumors through precise irradiation while protecting normal tissues.
4. Targeted therapy
Targeted drugs block cancer cell growth signals by focusing on specific molecular pathways. They are suitable for patients with certain genetic mutations.
5. Minimally invasive treatment
Minimally invasive techniques such as endoscopic mucosal resection and radiofrequency ablation offer early-stage gastric cancer patients options with less trauma and faster recovery, and are becoming increasingly common.
Stomach cancer poses significant health risks and requires a multidisciplinary treatment approach. Experts at the United Life International Medical Center emphasize the importance of early diagnosis and personalized treatment. As an emerging effective approach, immune reconstruction cell therapy brings new hope to patients. Active participation in professional treatment can improve quality of life and extend survival.
